Search results
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open for a Rival
Barrons.com· 1 day agoPfizer disclosed on May 7 that a child participating in another...
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 16 hours agoAre Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 22 hours agoPublic Employees Retirement System of Ohio reduced its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.8% during the 4th quarter, HoldingsChannel reports. The ...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 1 day agoSarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy...
Studio Investment Management LLC Buys 2,236 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 20 hours agoStudio Investment Management LLC increased its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.1% during the 4th quarter, according to the company in its most ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 1 day agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 2 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 2 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
Former Pfizer Worker’s 401(k) Account Won’t Be Given to Ex-Wife
Bloomberg Law· 13 hours agoemployee can’t access his 401(k) account to satisfy a $75,000 judgment against him in a defamation lawsuit, a Pennsylvania federal judge said. Judge Juan R. Sánchez rejected her request with ...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 3 days agoSome say the art of investing is the ability of catching falling knives. Pfizer Inc. (NYSE:PFE) shares have sold off in 2023 and represent an attractive...